$IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/

2024 Q1 Form 10-K Financial Statement

#000199937124003780 Filed on March 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $95.00K $30.00K $1.460M
YoY Change -82.31% -92.99% -10.21%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $95.00K $30.00K $1.460M
YoY Change -82.31% -92.99% -10.21%
Operating Profit -$95.00K -$30.00K -$1.460M
YoY Change -82.31% -92.99% -10.21%
Interest Expense $1.586M $2.910M $10.07M
YoY Change -15.01% 38.84% 52.53%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.491M $2.880M $8.610M
YoY Change 12.19% 72.66% 73.03%
Income Tax $313.0K $406.0K $1.609M
% Of Pretax Income 20.99% 14.1% 18.69%
Net Earnings $1.178M $2.474M $7.001M
YoY Change 12.19% 94.96% 78.1%
Net Earnings / Revenue
Basic Earnings Per Share $0.29 $0.60 $1.68
Diluted Earnings Per Share $0.29 $0.60 $1.68
COMMON SHARES
Basic Shares Outstanding 4.111M shares 4.168M shares 4.163M shares
Diluted Shares Outstanding 4.107M shares 4.163M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.00K $71.00K $71.00K
YoY Change 500.0% 1083.33% 1083.33%
Cash & Equivalents $36.00K $71.00K $71.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $107.3M $106.5M $106.5M
Other Receivables $107.3M $106.5M $0.00
Total Short-Term Assets $107.5M $106.9M $106.6M
YoY Change 5.5% 6.04% 6.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.17M $11.17M $11.47M
YoY Change 0.0% 0.0% -3.23%
TOTAL ASSETS
Total Short-Term Assets $107.5M $106.9M $106.6M
Total Long-Term Assets $11.17M $11.17M $11.47M
Total Assets $118.7M $118.1M $118.1M
YoY Change 4.95% 5.44% 5.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.000K $0.00
YoY Change -91.43% -100.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.000K
YoY Change -91.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.000K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.000K $0.00 $0.00
YoY Change -91.43% -100.0% -100.0%
SHAREHOLDERS EQUITY
Retained Earnings $58.21M $57.03M
YoY Change 13.96% 13.99%
Common Stock $62.00M $62.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.534M $947.0K
YoY Change 3833.33% 2328.21%
Treasury Stock Shares
Shareholders Equity $118.7M $118.1M $118.1M
YoY Change
Total Liabilities & Shareholders Equity $118.7M $118.1M $118.1M
YoY Change 4.95% 5.44% 5.44%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.178M $2.474M $7.001M
YoY Change 12.19% 94.96% 78.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $552.0K $963.0K $973.0K
YoY Change -19360.0% 24225.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $908.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$587.0K -908.0K -$908.0K
YoY Change
NET CHANGE
Cash From Operating Activities $552.0K 963.0K $973.0K
Cash From Investing Activities
Cash From Financing Activities -$587.0K -908.0K -$908.0K
Net Change In Cash -$35.00K 55.00K $65.00K
YoY Change -1200.0% 1525.0%
FREE CASH FLOW
Cash From Operating Activities $552.0K $963.0K $973.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2023 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
usd
CY2022 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
106541000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
100134000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
106905000 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
usd
CY2023 ior Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
usd
CY2022 ior Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
usd
CY2021 ior Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
usd
CY2023 ior Income Tax Reconciliation Temporary Differences
IncomeTaxReconciliationTemporaryDifferences
usd
CY2022 ior Income Tax Reconciliation Temporary Differences
IncomeTaxReconciliationTemporaryDifferences
usd
CY2021 ior Income Tax Reconciliation Temporary Differences
IncomeTaxReconciliationTemporaryDifferences
usd
CY2023 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
usd
CY2022 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
usd
CY2021 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
usd
CY2023 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
usd
CY2022 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
6600000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4110714 shares
CY2023 dei Auditor Name
AuditorName
FARMER, FUQUA & HUFF, PC
CY2023 dei Auditor Location
AuditorLocation
Richardson, Texas
CY2023 dei Auditor Firm
AuditorFirmId
782
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
293000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
676000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
100816000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
11173000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
11173000 usd
CY2023Q4 us-gaap Assets
Assets
118078000 usd
CY2022Q4 us-gaap Assets
Assets
111989000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4110714 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
62961 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
947000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57028000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50027000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118078000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118078000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111989000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
490000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
451000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
470000 usd
CY2022 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
1175000 usd
CY2021 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
1108000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1578000 usd
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1179000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1045000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
956000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3598000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3598000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3931000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
7001000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
7001000 usd
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
908000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118078000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
7001000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3931000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3598000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1017000 usd
CY2023 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-383000 usd
CY2022 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
85000 usd
CY2021 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-213000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
6407000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3834000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
5774000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
973000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2980000 usd
CY2021 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
2970000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2970000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
908000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-908000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
65000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zKH3pWB7JN5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zOspZfclszZ7">Concentration of credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash balances at commercial banks and through investment companies, the deposits that are insured by the Federal Deposit Insurance Corporation (FDIC). During the years ended December 31, 2023 and 2022, the Company did not maintain balances in excess of the insured amount.</span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_z2ZevmadHDy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zbdND7mwqQq4">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the preparation of consolidated financial statements in conformity with GAAP, it is necessary for management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expense for the year ended. Actual results could differ from those estimates.</span></p>
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1650000 shares
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
57700 shares
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1609000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1045000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
956000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1609000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1045000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
956000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1609000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1045000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
956000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1609000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1045000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
956000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.046 pure
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-537000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-456000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-437000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-30000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1834000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1643000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2474000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-460000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-341000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-397000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-428000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
626000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
848000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1188000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1269000 usd
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
11173000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
11173000 usd
CY2020Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
13126000 usd
CY2021 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
1953000 usd
CY2023Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
11173000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
11173000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
11173000 usd

Files In Submission

Name View Source Status
0001999371-24-003780-index-headers.html Edgar Link pending
0001999371-24-003780-index.html Edgar Link pending
0001999371-24-003780.txt Edgar Link pending
0001999371-24-003780-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex26-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ior-10k_123123.htm Edgar Link pending
ior-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ior-20231231_cal.xml Edgar Link unprocessable
ior-20231231_def.xml Edgar Link unprocessable
ior-20231231_lab.xml Edgar Link unprocessable
ior-20231231_pre.xml Edgar Link unprocessable
ior-10k_123123_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending